2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model
Lei Peng,1 Allison N Schorzman,2 Ping Ma,1 Andrew J Madden,2 William C Zamboni,2–4 Soumya Rahima Benhabbour,1 Russell J Mumper1,4 1Center for Nanotechnology in Drug Delivery, Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hil...
Guardado en:
Autores principales: | Peng L, Schorzman AN, Ma P, Madden AJ, Zamboni WC, Benhabbour SR, Mumper RJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8071f753f3c24c3bad81a94c0084f4b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo
por: Feng L, et al.
Publicado: (2011) -
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
por: Sarah E. Woodfield, et al.
Publicado: (2017) -
Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer
por: Xiao W, et al.
Publicado: (2012) -
Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells
por: Myoung Hwa Kim, et al.
Publicado: (2021) -
Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development.
por: Timothy W Corson, et al.
Publicado: (2014)